Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) |
Date |
Article Title | Journal |
|---|---|---|---|
|
Takuma Oda, Shih-Wei Chiu, Takuhiro Yamaguchi |
July 2021 | Semi-automated Conversion of Clinical Trial Legacy Data into CDISC SDTM Standards Format Using Supervised Machine Learning | Methods of Information in Medicine |
|
Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James Hillis, Teilo H Schaller, Anthony A Amato, Allison Betof Warner, Priscilla K Brastianos, Tracey A Cho, Stacey L Clardy, Justine V Cohen, Jorg Dietrich, Michael Dougan, Christopher T Doughty, Divyanshu Dubey, Jeffrey M Gelfand, Jeffrey T Guptill, Douglas B Johnson, Vern C Juel, Robert Kadish, Noah Kolb, Nicole R LeBoeuf, Jenny Linnoila, Andrew L Mammen, Maria Martinez-Lage, Meghan J Mooradian, Jarushka Naidoo, Tomas G Neilan, David A Reardon, Krista M Rubin, Bianca D Santomasso, Ryan J Sullivan, Nancy Wang, Karin Woodman, Leyre Zubiri, William C Louv, Kerry L Reynolds |
July 2021 | Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors | Journal for ImmunoTherapy of Cancer |
|
Hirotaka Miyashita, Christina Cruz, Vaibhav Patel |
August 2021 | Risk factors of skeletal-related events in patients with bone metastatic castration-resistant prostate cancer undergoing treatment with zoledronate | Supportive Care in Cancer |
|
Olutomilayo Olayemi Petinrin; Xiangtao Li; Ka-Chun Wong |
August 2021 | Particle Swarm Optimized Gaussian Process Classifier for Treatment Discontinuation Prediction in Multicohort Metastatic Castration-Resistant Prostate Cancer Patients | IEEE Journal of Biomedical and Health Informatics |
|
Enrique Vazquez, Henri Gouraud, Florian Naudet, Cary P Gross, Harlan M Krumholz, Joseph S Ross, Joshua D Wallach |
August 2021 | Characteristics of available studies and dissemination of research using major clinical data sharing platforms | Clinical Trials |
|
Kirit Singh, Kristen A. Batich, Patrick Y. Wen, Aaron C. Tan, Stephen J. Bagley, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Susan M. Chang, Rifaquat Rahman, Evanthia Galanis, Alireza Mansouri, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John H. Sampson, John Simes, Donald A. Berry, Gelareh Zadeh, Tim F. Cloughesy, Minesh P. Mehta, Steven Piantadosi,Michael Weller, Amy B. Heimberger |
September 2021 | Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma | American Association for Cancer Research |
|
Rifaquat Rahman, Steffen Ventz, Jon McDunn, Bill Louv, Irmarie Reyes-Rivera, Mei-Yin C Polley, Fahar Merchant, Lauren E Abrey, Joshua E Allen, Laura K Aguilar, Estuardo Aguilar-Cordova, David Arons, Kirk Tanner, Stephen Bagley, Mustafa Khasraw, Prof Timothy Cloughesy, Prof Patrick Y Wen, Brian M Alexander, Lorenzo Trippa |
September 2021 | Leveraging external data in the design and analysis of clinical trials in neuro-oncology | Lancet Oncology |
|
Ran Zeng, Fang Liu, Chen Fang, Jin Yang, Lifeng Luo, Ping Yue, Beili Gao, Yuchao Dong, and Yi Xiang |
October 2021 | PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients | Frontiers in Immunology |
|
Fionán Donohoea, Yvonne O'Mearaa, AidinRoberts, Louise Comerford, Catherine M. Kelly, JaniceM. Walshe, Michelle Peate, Marth aHickey, Donal J.Brennan |
November 2021 | The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study | Contemporary Clinical Trials Communications |
|
Giorgos Bakoyannis, Dipankar Bandyopadhyay |
November 2021 | Nonparametric tests for multistate processes with clustered data | AISM |
|
Leeann B Burton, Mahsa Eskian, Amanda C Guidon, Kerry L Reynolds |
November 2021 | A review of neurotoxicities associated with immunotherapy and a framework for evaluation | Neuro-Oncology Advances |
|
Anne A. Eaton, Emily C. Zabor |
December 2021 | Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules | Statistics in Medicine |
|
Shiyu Jiang, Liling Huang, Hongnan Zhen, Peijie Jin, Jing Wang & Zhihuang Hu |
December 2021 | Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis | BMC Cancer |
|
Jie Zhou, Xun Jiang, Hong Amy Xia, Peng Wei, Brian P. Hobbs |
December 2021 | Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response | Statistics in Medicine |
